What You Should Know:
– Glooko, a provider of integrated digital health solutions for diabetes management, has announced a significant expansion of its platform’s capabilities with the integration of Abbott’s FreeStyle Libre continuous glucose monitoring…
Continue Reading
What You Should Know:
– Senseonics Holdings and Ascensia Diabetes Care today announced the integration of the Eversense® 365 Continuous Glucose Monitoring (CGM) System with the SweetSpot™ diabetes management platform in the U.S.
– The collaboration…
Continue Reading
What You Should Know:
– Abbott, a global healthcare company, has announced the U.S. availability of Lingo, a continuous glucose monitoring (CGM) system designed for individuals who want to improve their overall health and wellness.
–…
Continue Reading
What You Should Know: – A large majority of physicians feel GLP-1s are being overprescribed, according to a new survey from Virta Health, a leader in type 2 diabetes reversal. – The Virta Health…
Continue Reading
What You Should Know:
– At the American Diabetes Association conference, Abbott unveiled a new addition to its FreeStyle Libre portfolio – the FreeStyle Libre 3 Plus sensor.
– The sensor boasts the distinction of being…
Continue Reading
What You Should Know:
– Digital diabetes management tools are failing to deliver meaningful health benefits to patients, according to a new evaluation by the Peterson Health Technology Institute (PHTI).
– The report casts doubt on…
Continue Reading
What You Should Know:
Rimidi, a clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, is announcing enhancements to its diabetes management platform, including the addition of Glycemic Risk…
Continue Reading
